Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids
1.0.0-cibuild - CIBuild United States of America flag

Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-cibuild built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cdc-opioid-cpg/ and changes regularly. See the Directory of published versions

Home

Official URL: http://hl7.org/fhir/us/cdc-opioid-cpg/ImplementationGuide/hl7.fhir.us.cdc-opioid-cpg Version: 1.0.0-cibuild
Active as of 2024-11-27 Computable Name: CDCOpioidCPG

Summary

Defines exchange expectations for systems that implement the 2022 CDC Clinical Practice Guideline for Prescribing Opioids, both in terms of the data required to evaluate whether recommendations are applicable, as well as the data required to represent proposals resulting from those recommendations.

TODO

Scope of Use

TODO

How to read this Guide

Target Audiences

TODO

Acknowledgements

This Implementation Guide was made possible by the thoughtful contributions of the following people and organizations:

TODO

References

TODO

Dependencies

IGPackageFHIRComment
.. Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioidshl7.fhir.us.cdc-opioid-cpg#1.0.0-cibuildR4
... HL7 Terminology (THO)hl7.terminology.r4#6.1.0R4Automatically added as a dependency - all IGs depend on HL7 Terminology
... FHIR Extensions Packhl7.fhir.uv.extensions.r4#5.1.0R4Automatically added as a dependency - all IGs depend on the HL7 Extension Pack

Cross Version Analysis

This is an R4 IG. None of the features it uses are changed in R4B, so it can be used as is with R4B systems. Packages for both R4 (hl7.fhir.us.cdc-opioid-cpg.r4) and R4B (hl7.fhir.us.cdc-opioid-cpg.r4b) are available.

Global Profiles

There are no Global profiles defined

IP Statements

This publication includes IP covered under the following statements.